These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 13681256)

  • 1. Excretion of porphobilinogen and 5-aminolaevulinic acid in acute porphyria.
    ACKNER B; COOPER JE; GRAY CH; KELLY M; NICHOLSON DC
    Lancet; 1961 Jun; 1(7189):1256-60. PubMed ID: 13681256
    [No Abstract]   [Full Text] [Related]  

  • 2. Excretion of porphobilinogen and Delta-aminolaevulinic acid in acute porphyria.
    WITH TK
    Lancet; 1961 Aug; 2(7200):485-6. PubMed ID: 13786050
    [No Abstract]   [Full Text] [Related]  

  • 3. [On the excretion of 5-aminolevulinic acid and porphobilinogen in latent porphyria].
    KELENYI G; ARATO G; BUDA V; ORBAN S
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1961; 78():205-13. PubMed ID: 14454906
    [No Abstract]   [Full Text] [Related]  

  • 4. Porphyria induced in the rabbit by diethyl 1,4-dihydro-2,4,6-trimethylpyridine-3,5-dicarboxylate. I. Excretion of 5-aminolaevulic acid, porphobilinogen, coproporphyrin and protoporphyrin.
    HAEGER-ARONSEN B
    Acta Pharmacol Toxicol (Copenh); 1961; 18():165-9. PubMed ID: 13903511
    [No Abstract]   [Full Text] [Related]  

  • 5. [On the problem of treatment of acute intermittent porphyria with ovulation inhibitors. (Studies of delta-aminolevulinic acid, porphobilinogen and total porphyrin excretion)].
    Hocevar V; Rausch-Stroomann JG
    Klin Wochenschr; 1968 Oct; 46(20):1114-6. PubMed ID: 5706556
    [No Abstract]   [Full Text] [Related]  

  • 6. [Excretion of delta-aminolevulinic acid and porphobilinogen in experimental porphyria in rabbits].
    JANOUSEK V; OCENASEK M
    Cesk Fysiol; 1960 Jan; 9():82-3. PubMed ID: 14406722
    [No Abstract]   [Full Text] [Related]  

  • 7. Urinary excretion of porphobilinogen in acute porphyria.
    KELENYI G; ARATO G; BUDA V; ORBAN S
    Lancet; 1960 Feb; 1(7121):434. PubMed ID: 13853339
    [No Abstract]   [Full Text] [Related]  

  • 8. Porphobilinogen and delta-amino levulinic acid in acute porphyria.
    GRANICK S; VANDEN SCHRIECK HG
    Proc Soc Exp Biol Med; 1955 Feb; 88(2):270-3. PubMed ID: 14357411
    [No Abstract]   [Full Text] [Related]  

  • 9. Urinary dipyrrylmethenes in patients with porphyria. A preliminary study of the brown pigments in the urine of a case of acute intermittent porphyria.
    Sears WG; Eales L
    Enzyme; 1974; 17(1):11-6. PubMed ID: 4836422
    [No Abstract]   [Full Text] [Related]  

  • 10. Urinary delta-aminolaevulic acid and porphobilinogen in different types of porphyria.
    HAEGER B
    Lancet; 1958 Sep; 2(7047):606-8. PubMed ID: 13588944
    [No Abstract]   [Full Text] [Related]  

  • 11. Abnormal urinary amino acid patterns in acute intermittent porphyria.
    MELLINKOFF SM; HALPERN RM; FRANKLAND M; GREIPEL M
    J Lab Clin Med; 1959 Mar; 53(3):358-63. PubMed ID: 13631320
    [No Abstract]   [Full Text] [Related]  

  • 12. Quantitation of 3-ethyl-5-hydroxy-4,5-dimethyl-delta 3-pyrrolin-2-one in the urine of patients with acute intermittent porphyria.
    Graham DJ; Brodie MJ; McColl KE; Moore MR; Goldberg A
    Eur J Clin Invest; 1979 Feb; 9(1):49-53. PubMed ID: 110600
    [No Abstract]   [Full Text] [Related]  

  • 13. Delta-amino-levulinic acid, porphobilinogen, and porphyrin excretion throughout pregnancy in a patient with acute intermittent porphyria with "passive porphyria" in the infant.
    JAMES GW; RUDOLPH SG; ABBOTT LD
    J Lab Clin Med; 1961 Sep; 58():437-44. PubMed ID: 13789298
    [No Abstract]   [Full Text] [Related]  

  • 14. Isolation of porphobilinogen from the urine of a patient with acute porphyria.
    WESTALL RG
    Nature; 1952 Oct; 170(4328):614-6. PubMed ID: 13002380
    [No Abstract]   [Full Text] [Related]  

  • 15. [A new biochemical difference between human acute porphyria and experimental porphyria].
    STICH W
    Klin Wochenschr; 1958 Apr; 36(8):386-9. PubMed ID: 13550842
    [No Abstract]   [Full Text] [Related]  

  • 16. PORPHOBILINOGEN AND DELTA-AMINOLEVULINIC ACID EXCRETION IN MULTIPLE SCLEROSIS.
    TAYLOR JD; PAZDER LH; MARKLE V
    Can Med Assoc J; 1965 Jun; 92(26):1342-4. PubMed ID: 14312444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Qualitative demonstration of porphobilinogen in the urine in the framework of diagnosis of porphyria].
    Fillippini L; Siegenthaler W
    Dtsch Med Wochenschr; 1967 Apr; 92(15):718-9. PubMed ID: 6023750
    [No Abstract]   [Full Text] [Related]  

  • 18. Repression of the overproduction of porphyrin precursors in acute intermittent porphyria by intravenous infusions of hematin.
    Bonkowsky HL; Tschudy DP; Collins A; Doherty J; Bossenmaier I; Cardinal R; Watson CJ
    Proc Natl Acad Sci U S A; 1971 Nov; 68(11):2725-9. PubMed ID: 5288250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FACTORS AFFECTING THE EXCRETION OF PORPHYRIN PRECURSORS BY PATIENTS WITH ACUTE INTERMITTENT PORPHYRIA. I. THE EFFECT OF DIET.
    WELLAND FH; HELLMAN ES; GADDIS EM; COLLINS G; HUNTER GW; TSCHUDY DP
    Metabolism; 1964 Mar; 13():232-50. PubMed ID: 14127691
    [No Abstract]   [Full Text] [Related]  

  • 20. FACTORS AFFECTING THE EXCRETION OF PORPHYRIN PRECURSORS BY PATIENTS WITH ACUTE INTERMITTENT PORPHYRIA. II. THE EFFECT OF ETHINYL ESTRADIOL.
    WELLAND FH; HELLMAN ES; COLLINS A; HUNTER GW; TSCHUDY DP
    Metabolism; 1964 Mar; 13():251-8. PubMed ID: 14127692
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.